Literature DB >> 20727829

MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway.

Davide Cacchiarelli1, Julie Martone1, Erika Girardi1, Marcella Cesana1, Tania Incitti1, Mariangela Morlando1, Carmine Nicoletti2, Tiziana Santini1, Olga Sthandier1, Laura Barberi2, Alberto Auricchio3, Antonio Musarò2, Irene Bozzoni4.   

Abstract

In Duchenne muscular dystrophy (DMD) the absence of dystrophin at the sarcolemma delocalizes and downregulates nitric oxide synthase (nNOS); this alters S-nitrosylation of HDAC2 and its chromatin association. We show that the differential HDAC2 nitrosylation state in Duchenne versus wild-type conditions deregulates the expression of a specific subset of microRNA genes. Several circuitries controlled by the identified microRNAs, such as the one linking miR-1 to the G6PD enzyme and the redox state of cell, or miR-29 to extracellular proteins and the fibrotic process, explain some of the DMD pathogenetic traits. We also show that, at variance with other myomiRs, miR-206 escapes from the dystrophin-nNOS control being produced in activated satellite cells before dystrophin expression; in these cells, it contributes to muscle regeneration through repression of the satellite specific factor, Pax7. We conclude that the pathway activated by dystrophin/nNOS controls several important circuitries increasing the robustness of the muscle differentiation program.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727829     DOI: 10.1016/j.cmet.2010.07.008

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  119 in total

1.  Decreased myoblast differentiation in chronic binge alcohol-administered simian immunodeficiency virus-infected male macaques: role of decreased miR-206.

Authors:  L Simon; S M Ford; K Song; P Berner; C Vande Stouwe; S Nelson; G J Bagby; P E Molina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-06-21       Impact factor: 3.619

2.  SMYD1 and G6PD modulation are critical events for miR-206-mediated differentiation of rhabdomyosarcoma.

Authors:  Davide Martino Coda; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Francesca Bersani; Ugo Ala; Carola Ponzetto; Riccardo Taulli
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice.

Authors:  Rimao Wu; Hu Li; Lili Zhai; Xiaoting Zou; Jiao Meng; Ran Zhong; Changyin Li; Haixia Wang; Yong Zhang; Dahai Zhu
Journal:  Nat Commun       Date:  2015-07-07       Impact factor: 14.919

4.  PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis.

Authors:  P Briata; W-J Lin; M Giovarelli; M Pasero; C-F Chou; M Trabucchi; M G Rosenfeld; C-Y Chen; R Gherzi
Journal:  Cell Death Differ       Date:  2011-09-02       Impact factor: 15.828

5.  S100B protein in skeletal muscle regeneration: regulation of myoblast and macrophage functions.

Authors:  F Riuzzi; S Beccafico; G Sorci; R Donato
Journal:  Eur J Transl Myol       Date:  2016-02-23

Review 6.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

Review 7.  MicroRNAs in skeletal myogenesis.

Authors:  Yejing Ge; Jie Chen
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

8.  Overexpression of NF90-NF45 Represses Myogenic MicroRNA Biogenesis, Resulting in Development of Skeletal Muscle Atrophy and Centronuclear Muscle Fibers.

Authors:  Hiroshi Todaka; Takuma Higuchi; Ken-ichi Yagyu; Yasunori Sugiyama; Fumika Yamaguchi; Keiko Morisawa; Masafumi Ono; Atsuki Fukushima; Masayuki Tsuda; Taketoshi Taniguchi; Shuji Sakamoto
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

9.  Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.

Authors:  Francesca Bersani; Marcello Francesco Lingua; Deborah Morena; Valentina Foglizzo; Silvia Miretti; Letizia Lanzetti; Giovanna Carrà; Alessandro Morotti; Ugo Ala; Paolo Provero; Roberto Chiarle; Samuel Singer; Marc Ladanyi; Thomas Tuschl; Carola Ponzetto; Riccardo Taulli
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 12.701

Review 10.  MicroRNA in myogenesis and muscle atrophy.

Authors:  Xiaonan H Wang
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-05       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.